NEUARTIGER ANTI-CMET-ANTIKÖRPER

European patent · EP2575879 · In force

Register entry

Publication number
EP2575879
Application number
EP11722828
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jun 1, 2011
Published
Apr 10, 2013
Granted
Apr 20, 2016
Protection ends at the latest
May 31, 2031
Next annual fee due
Jun 30, 2027
IPC classes
A61K 39/00 (2006.01)
A61K 39/395 (2006.01)
A61P 35/00 (2006.01)
C07K 16/00 (2006.01)
C07K 16/28 (2006.01)
C07K 16/30 (2006.01)
Priority
US 791681 01.06.2010
PCT application
PCT/EP2011/059139 01.06.2011
PCT publication
WO2011/151412 08.12.2011
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jul 1, 2026

    Next annual fee due on

    Next annual fee due on
    30.06.2026 → 30.06.2027

    Published in Swissreg on 01.07.2026

  2. Jul 1, 2025

    Next annual fee due on

    Next annual fee due on
    30.06.2025 → 30.06.2026

    Published in Swissreg on 01.07.2025

  3. Jul 4, 2024

    Change

    Published in Swissreg on 04.07.2024

  4. Jul 1, 2023

    Change

    Published in Swissreg on 01.07.2023

  5. Jul 1, 2022

    Change

    Published in Swissreg on 01.07.2022

  6. Jul 16, 2016

    Agent entered

    Representative
    MICHELI & CIE SA, 122, Rue de Genève, Case postale 61, 1226 Thônex

    Published in Swissreg on 16.07.2016

  7. Apr 20, 2016

    Granted

    Published in Swissreg on 20.04.2016

Parties

Holder

Pierre Fabre Médicament

92100 Boulogne-Billancourt, FR

Agent

MICHELI & CIE SA

122, Rue de Genève Case postale 61, 1226 Thônex

Inventor

GOETSCH, Liliane

F-74130 Ayze, FR

WURCH, Thierry

F-74140 Machilly, FR

BES, Cédric

F-30250 Villevieille, FR

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.